Through RT-qPCR, we found that MRFs (MyoD, MyoG, Mef2C, and Mrf4) were significantly inhibited in the DM1 group during in vitro myoblast differentiation. The gene discussed is MYOD1; the disease is myotonic dystrophy type 1.